VAD Regimen as Initial Treatment for Multiple Myeloma

"nIntroduction: The aim of our study is evaluation of response rate of VAD (Vincristin, Adriamycin and Dexamethason) regimen as initial treatment in 40 new cases of multiple myeloma. This is the first systemic and classic report of VAD regimen in Iranian population. "nMethods: All...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Mohammad Ali Mashhadi, Mehdi Hashemi, Negin Khosravi
Formaat: Artikel
Taal:English
Gepubliceerd in: Tehran University of Medical Sciences 2010-10-01
Reeks:International Journal of Hematology-Oncology and Stem Cell Research
Onderwerpen:
Online toegang:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/18882.pdf&manuscript_id=18882